Evidence map›Paper›PMID 24053144›Full record

ArticleMalaria journal2013

Assessing malaria transmission in a low endemicity area of north-western Peru.

Angel Rosas-Aguirre, Alejandro Llanos-Cuentas, Niko Speybroeck, Jackie Cook, Juan Contreras-Mancilla, Veronica Soto, Dionicia Gamboa, Edwar Pozo, Oscar J Ponce, Mayne O Pereira and 4 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Serology reveals comparable patterns in the transmission intensities ofFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  12. Life (Basel, Switzerland) · 2023
    Article
  13. Serology reveals micro-differences inFrontiers in parasitology · 2023
    Article
  14. Naturally acquired antibody response toFrontiers in cellular and infection microbiology · 2023
    Article
  15. Article
  16. PvMSP8 as a NovelPathogens (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Mapping Multi-Disease Risk during El Niño: An Ecosyndemic Approach.International journal of environmental research and public health · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 6 countries.

Angel Rosas-AguirreInstituto de Medicina Tropical, Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru. angelrosasa@gmail.com.
Alejandro Llanos-Cuentas
Niko Speybroeck
Jackie Cook
Juan Contreras-Mancilla
Veronica Soto
Dionicia Gamboa
Edwar Pozo
Oscar J Ponce
Mayne O Pereira
Irene S Soares
Michael Theisen
Umberto D'Alessandro
Annette Erhart
Universidad Peruana Cayetano Heredia · PEUniversidade de São Paulo · BRDirección Regional de Salud del Callao · PEInstituut voor Tropische Geneeskunde · BEKarolinska Institutet · SEMRC Unit the Gambia · GMUCLouvain · BEUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhere malaria endemicity is low, control programmes need increasingly sensitive tools for monitoring malaria transmission intensity (MTI) and to better define health priorities. A cross-sectional survey was conducted in a low endemicity area of the Peruvian north-western coast to assess the MTI using both molecular and serological tools.

methodsEpidemiological, parasitological and serological data were collected from 2,667 individuals in three settlements of Bellavista district, in May 2010. Parasite infection was detected using microscopy and polymerase chain reaction (PCR). Antibodies to Plasmodium vivax merozoite surface protein-119 (PvMSP1₁₉) and to Plasmodium falciparum glutamate-rich protein (PfGLURP) were detected by ELISA. Risk factors for exposure to malaria (seropositivity) were assessed by multivariate survey logistic regression models. Age-specific antibody prevalence of both P. falciparum and P. vivax were analysed using a previously published catalytic conversion model based on maximum likelihood for generating seroconversion rates (SCR).

resultsThe overall parasite prevalence by microscopy and PCR were extremely low: 0.3 and 0.9%, respectively for P. vivax, and 0 and 0.04%, respectively for P. falciparum, while seroprevalence was much higher, 13.6% for P. vivax and 9.8% for P. falciparum. Settlement, age and occupation as moto-taxi driver during previous year were significantly associated with P. falciparum exposure, while age and distance to the water drain were associated with P. vivax exposure. Likelihood ratio tests supported age seroprevalence curves with two SCR for both P. vivax and P. falciparum indicating significant changes in the MTI over time. The SCR for PfGLURP was 19-fold lower after 2002 as compared to before (λ1 = 0.022 versus λ2 = 0.431), and the SCR for PvMSP1₁₉ was four-fold higher after 2006 as compared to before (λ1 = 0.024 versus λ2 = 0.006).

conclusionCombining molecular and serological tools considerably enhanced the capacity of detecting current and past exposure to malaria infections and related risks factors in this very low endemicity area. This allowed for an improved characterization of the current human reservoir of infections, largely hidden and heterogeneous, as well as providing insights into recent changes in species specific MTIs. This approach will be of key importance for evaluating and monitoring future malaria elimination strategies.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ProtozoanChildChild, PreschoolCross-Sectional StudiesDNA, ProtozoanEnzyme-Linked Immunosorbent AssayFemaleHumansInfantInfant, NewbornMalaria, FalciparumMalaria, VivaxAntibodies, ProtozoanDNA, Protozoan

Identifiers

PMID24053144
PMCPMC3849384
OpenAlexW2168373426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.